Cyclerion Therapeutics, Inc. Gains 24.76%

Mon, Oct 24, 2022 at 07:35 PM
Cyclerion Therapeutics, Inc. Gains 24.76%

Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) soared at $0.47, representing a gain of 24.8%. On Mon, Oct 24, 2022, CYCN:NASDAQ touched a New 2-Week High of $0.47. The stock appeared on our News Catalysts scanner on Thu, Oct 06, 2022 at 08:41 AM in the 'INVESTOR UPDATE' category. From Mon, Oct 10, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days

The stock spiked on Mon, Oct 24, 2022 at $0.6 with a volume of 2M+.

About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.